A team of researchers, led by the Radcliffe Department of Medicine, has found that a single, integrated health check carried out in a primary care setting can accurately predict risks for diseases across multiple organs.
RDM is delighted to announce the conferment of three new Associate Professors. Each of our new Associate Professors has been awarded the title in recognition of their contributions to research, teaching and citizenship at the University and beyond.
Research led by scientists from the Universities of Oxford and Edinburgh has found that early good blood glucose control can minimise the lifetime risk of diabetes-related complications, including heart attacks, kidney failure and vision loss.
Researchers from the Simmons and Koohy Groups in the Weatherall Institute of Molecular Medicine (WIMM) Translational Immune Discovery Unit have identified potential pathways by which cancer treatment can cause colitis.
Friends and colleagues of Professor Stephen Harrison, at the Radcliffe Department of Medicine, where he was a visiting professor, are deeply saddened to hear about his untimely passing. Our thoughts are with his family and friends at this difficult time.
For International Day of Immunology 2024, three scientists from the MRC Translational Immune Discovery Unit in the Weatherall Institute of Molecular Medicine (WIMM) speak about their research.
Collaborative research, led from NDPCHS and published today in Nature Medicine, has developed a new tool called QR4 that more accurately predicts an individual's 10-year risk of cardiovascular diseases, like heart disease and stroke, particularly identifying high-risk patients that current prediction tools miss.
Professor Graham Ogg, from the MRC Weatherall Institute of Molecular Medicine has been awarded funding for an international 8-year research programme from global charitable foundation Wellcome.
Following the Department\u2019s annual call for researchers to apply for Principal Investigator (PI) status, RDM is delighted to announce the designation of four new PIs for 2024.
Dementias Platform UK has been awarded over \u00a34 million to carry out countrywide trials to identify accurate and quick blood tests that can diagnose dementia, in a bid to improve management and patient and carer wellbeing. RDM's Diabetes Trials Unit will run the clinical trial component of the challenge.
Organised by the Parliamentary & Scientific Committee, STEM for BRITAIN is a major scientific poster competition and exhibition, held annually at the Houses of Parliament.
This World Cancer Day, we heard from four Group Leaders at the MRC Weatherall Institute of Molecular Medicine about their work and how their groups are helping in the fight against cancer.
![\"doctor](\"https://www.rdm.ox.ac.uk/news/study-outlines-feasibility-of-multiple-disease-risk-prediction-model-for-primary-care/responsive_image?ratio=r16x9&scale=w760\")
\n \n \n\n\n